Drugs / HDDO-1756
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04755894 | Jun 2020 | hyperlipidemia | Hyundai Pharmaceutical Co., LTD. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HDDO-1756 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04755894 ↗ |